TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02761733

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Moving Patient Outcomes toward Wellness and Recovery (mPOWR)
Description: An mPOWR intervention and toolkit that consists of strategies, prompts, and decision aids designed to foster patient involvement in treatment. The mPOWR intervention includes a questionnaire that assesses quality of life and consumer functioning for use in the development of consumer-centered goals and outcomes within the mPOWR intervention.
Study: NCT03550664

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Monitoring of neuromuscular transmission
Description: Monitoring of neuromuscular transmission will be done by TOFScan (IdMed, Marseille, France). This device is CE marked, and is used routinely in daily clinical practice. Prior to induction of anesthesia, the TOFScan is placed on a patient's hand and the two stimulation electrodes (ECG electrodes) are placed at the level of the ulnar nerve at the wrist. After induction of anesthesia and before administration of a curare, the TOFScan is calibrated according to the manufacturer's instructions. The TOFScan is placed in automatic mode, it will then automatically adapt its mode of stimulation to the depth of the curarization. The TOFScan measurements will be recorded on a PC connected to the TOFScan.
Study: NCT04402060

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: APL-9
Description: Complement (C3) Inhibitor

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle Control
Description: Normal saline of equal volume to active arm
Study: NCT04198597

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
Description: Please see arm/group descriptions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
Description: Please see arm/group descriptions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Process-based Cognitive Behavioral Therapy
Description: Please see arm/group descriptions

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Process-based Cognitive Behavioral Therapy
Description: Please see arm/group descriptions
Study: NCT01379287

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iso-Fludelone
Description: Iso-fludelone will be administered IV over 6 hours (+/- 30 mins) on Day 1 of every 3 week cycle.
Study: NCT00120523

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pimecrolimus
Description: Pimecrolimus cream 1 %
Study: NCT03558139

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magrolimab
Description: Administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magrolimab
Description: Administered intravenously
Study: NCT00120523

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Topical corticosteroids
Description: TCS
Study: NCT04569656

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hydrolyzed guar gum
Description: treatment with Stick pack 30 ml containing PHGG 5 gr e Hyaluronic Acid 200 mg for 6 weeks
Study: NCT04945577

Intervention type: DIAGNOSTIC_TEST
Intervention: Inflammatory Parameters
Description: Laboratory measurement of patient's inflammatory status in unit of % and mg/dl

Intervention type: DIAGNOSTIC_TEST
Intervention: Inflammatory Parameters
Description: Laboratory measurement of patient's inflammatory status in unit of % and mg/dl

Intervention type: DIAGNOSTIC_TEST
Intervention: Inflammatory Parameters
Description: Laboratory measurement of patient's inflammatory status in unit of % and mg/dl

Intervention type: OTHER
Intervention: 25 OH Vitamin D Level
Description: Laboratory measurement of patient's 25 OH vitamin D level in unit of ng/dl

Intervention type: OTHER
Intervention: 25 OH Vitamin D Level
Description: Laboratory measurement of patient's 25 OH vitamin D level in unit of ng/dl

Intervention type: OTHER
Intervention: 25 OH Vitamin D Level
Description: Laboratory measurement of patient's 25 OH vitamin D level in unit of ng/dl
Study: NCT02059252

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SmartMatrix dermal replacement scaffold
Description: SmartMatrix dermal replacement scaffold
Study: NCT03558139

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magrolimab
Description: Administered intravenously
Study: NCT04605042

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: wet suction
Description: Before pucturing the lesion, the stylet was removed and the needle was pre-flushed with 1-2 mL of saline using a 10-mL syringe, the endoscopist then punctured the lesion and replaced the 10-mL syringe with a 10-mL pre-vacuum syringe
Study: NCT01727635

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: body-mind-spirit group therapy
Description: 8-session therapy
Study: NCT03123354

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: O3 regional oximeter sensor
Description: Noninvasive sensor that is placed on the forehead for measurement of oxygenation in the area under the sensor
Study: NCT01544777

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Study IOL
Description: Aspheric IOL for correction of aphakia

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hoya iSert 751
Description: Model 751 in one eye, standard IOL in other eye

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Negatively aspheric IOL
Description: Negatively aspheric IOL in both eyes
Study: NCT04288804

Intervention type: DEVICE
Intervention: Smartphone microphone sensor
Description: The volunteer will record themselves sustaining the short a vowel sound for 10 seconds.

Intervention type: DEVICE
Intervention: Smartphone microphone sensor
Description: The volunteer will record themselves sustaining the short a vowel sound for 10 seconds.

Intervention type: DEVICE
Intervention: Smartphone accelerometer sensor
Description: The volunteer's smartphone's accelerometer will record accelerometer data (positions on the x, y, and z axes) while the volunteer maintains 4 positions, each for 10 seconds.

Intervention type: DEVICE
Intervention: Smartphone accelerometer sensor
Description: The volunteer's smartphone's accelerometer will record accelerometer data (positions on the x, y, and z axes) while the volunteer maintains 4 positions, each for 10 seconds.
Study: NCT03375112

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block
Description: The patient will be brought to the block room within 30 minutes of arriving in recovery. An injection of local anesthetic into the fascia iliaca compartment using ultrasound guidance will be administered. The patient will then be transported back to recovery.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The patient will be brought to the block room within 30 minutes of arriving in recovery. An ultrasound probe will be placed to the skin and a blunt needle will be touched to the patient's skin in the area that a fascia iliaca compartment block would be performed. The patient will then be transported back to recovery.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: A one time dose of 40 milliliters of 0.5% bupivacaine will be injected into the fascia iliaca compartment
Study: NCT03171896

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: clown
Description: A medical clown will be offerred to the parturient and will spend time with her during labor as long as she will want it
Study: NCT03171896

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: No clown will be present in the room during labor
Study: NCT04605042

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: standard negative pressure suction
Description: after puncturing the lesion, the endoscopist removed the stylet and attached a 10-mL pre-vacuum syringe for aspiration.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: standard negative pressure suction
Description: after puncturing the lesion, the endoscopist removed the stylet and attached a 10-mL pre-vacuum syringe for aspiration.
Study: NCT02713373

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Given IV

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study: NCT04200573

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ampreloxetine
Description: The study drug will be administered orally as a single Dose A tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ampreloxetine
Description: The study drug will be administered orally as a single Dose A tablet
Study: NCT02683993

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber
Description: The Lumenis Pulse P120H will be utilized in high and low frequencies according to subjects group allocation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber
Description: The Lumenis Pulse P120H will be utilized in high and low frequencies according to subjects group allocation.
Study: NCT03409770

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Description: Whole body cooling using a servo controlled device

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Description: Whole body cooling using a servo controlled device
Study: NCT02496000

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ORMD-0801
Description: Oral Insulin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ORMD-0801
Description: Oral Insulin

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Placebo
Study: NCT03543423

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test
Description: Oral glucose tolerance test will be carried out with a glucose solution made up of 75g glucose dissolved in 300mL. To the glucose solution will be added 5g 3-OMG and 1g paracetamol 5g 3-OMG

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Liquid mixed meal test
Description: A standardised liquid mixed meal test will be carried out using a standard liquid mixed meal (fresubin drink supplemented with 1g paracetamol).
Study: NCT03266783

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Apixaban
Description: Refer to Apixaban group
Study: NCT04241653

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pressure Support Ventilation
Description: Ventilator will be adjusted to administer pressure at 10 cmH2O.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Unparalyzed Pressure Control Ventilation
Description: Pressure controlled ventilation mode will be applied to obtain a volume of 8 ml/kg up to 20 cmH2O. The set respiratory rate will be 15 breaths/min then it is adjusted to achieve the end tidal CO2 levels between 35 and 40 mmHg as measured by capnography.
Study: NCT03266783

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rivaroxaban
Description: Refer to Rivaroxaban group
Study: NCT03913130

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QR-110
Description: First treated eye: maintenance dose every 6 months, intravitreal administration Contralateral eye: loading dose followed by maintenance dose, every 6 months, intravitreal administration
Study: NCT03826472

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Almond Butter
Description: Natural almond butter
Study: NCT00380146

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sulfadoxine-pyrimethamine
Study: NCT02478281

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methylene Blue
Study: NCT02731560

Intervention type: DRUG
Group type: OTHER
Intervention: Rituximab
Description: Rituximab was administered as an intravenous infusion as per approved protocol on Day 1 and day 14. The protocol stipulated the administration of intravenous hydrocortisone 100 mg and oral pheniramine maleate 43.5 mg as pre-medication. The Rituximab itself was given as a 1 gm infusion slowly over a period of 4-6 hours.~This was done either by a specialist nurse or a trained doctor.
Study: NCT04241653

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Paralyzed Pressure Control Ventilation
Description: Pressure controlled ventilation mode will be applied to obtain a volume of 8 ml/kg up to 20 cmH2O. The set respiratory rate will be 15 breaths/min then it is adjusted to achieve the end tidal CO2 levels between 35 and 40 mmHg as measured by capnography. Also, neuromuscular blockade will be achieved.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laryngeal Mask Airway
Description: Capnography connected to laryngeal mask airway is introduced after adequate jaw relaxation; its size is chosen according to the body weight of the child.
Study: NCT03249649

Intervention type: BEHAVIORAL
Intervention: Comprehensive Healthcare Needs Assessment
Description: Questionnaire focused on existing healthcare communication, treatment and services plus community needs in those three areas.

Intervention type: BEHAVIORAL
Intervention: Comprehensive Healthcare Needs Assessment
Description: Questionnaire focused on existing healthcare communication, treatment and services plus community needs in those three areas.
Study: NCT00238888

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: asthma control awareness
Description: Repeated assessments of the child's asthma control using the Asthma Quiz for Kidz, with recommendation for asthma education and medical visit

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Recommendation for asthma education and/or follow-up at the physician's discretion
Study: NCT04495933

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg
Description: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 15mcg
Description: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 15mcg

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 45mcg
Description: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 45mcg

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: sterile saline

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: sterile saline
Study: NCT04241653

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laryngeal Mask Airway
Description: Capnography connected to laryngeal mask airway is introduced after adequate jaw relaxation; its size is chosen according to the body weight of the child.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laryngeal Mask Airway
Description: Capnography connected to laryngeal mask airway is introduced after adequate jaw relaxation; its size is chosen according to the body weight of the child.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Sevoflurane in air/oxygen mixture of 40% will be titrated to achieve adequate depth of anesthesia to maintain immobilization of the eye.
Study: NCT04495933

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: sterile saline
Study: NCT03427671

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Occlusin 500 Microspheres
Description: Occlusin 500 microspheres will be administered using a catheter directed to the uterine vasculature using fluoroscopy. The microsphere suspension will be administered to a near-stasis endpoint.
Study: NCT02256371

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hypnosis sessions
Description: 1 session per week during 8 weeks
Study: NCT04241653

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Sevoflurane in air/oxygen mixture of 40% will be titrated to achieve adequate depth of anesthesia to maintain immobilization of the eye.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Sevoflurane in air/oxygen mixture of 40% will be titrated to achieve adequate depth of anesthesia to maintain immobilization of the eye.
Study: NCT01536730

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Homework Intervention Strategy
Description: Participants assigned to intervention will receive a condom ditty bag containing 50 condoms (5 each of 10 types), a variety of 50 lubricants, an instructional DVD, and instructions for the intervention.
Study: NCT02364518

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Snoreplasty
Description: The procedure will be performed under local anesthesia in the examination chair. The subject's throat will be anesthetized with benzocaine spray followed by infiltration of the soft palate with 4-5 milliliters of 1% lidocaine with 1:100,000 epinephrine. The TranQuill suture will be inserted into the soft palate tissues using a predescribed pattern.
Study: NCT01081223

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cancer vaccine plus immune adjuvant
Description: Tumor tissue is used for cancer vaccine. Following vaccinations, white blood cells are collected, stimulated and expanded, and are then reinfused. The infusion is followed by a course of low-dose IL-2.
Study: NCT01916122

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorestradiol (FES)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PET/CT Imaging
Study: NCT03605810

Intervention type: OTHER
Intervention: No Intervention
Description: This study is the development of algorithms/models to predict eGFR values and/or classes for patients at certain time point based on entries in claims database (demographic characteristics, clinical diagnoses, procedures and drug treatments) for a general population and a variety of use-cases (AF, CAD, T2DM patients sub-populations).

Intervention type: OTHER
Intervention: No Intervention
Description: This study is the development of algorithms/models to predict eGFR values and/or classes for patients at certain time point based on entries in claims database (demographic characteristics, clinical diagnoses, procedures and drug treatments) for a general population and a variety of use-cases (AF, CAD, T2DM patients sub-populations).

Intervention type: OTHER
Intervention: No Intervention
Description: This study is the development of algorithms/models to predict eGFR values and/or classes for patients at certain time point based on entries in claims database (demographic characteristics, clinical diagnoses, procedures and drug treatments) for a general population and a variety of use-cases (AF, CAD, T2DM patients sub-populations).

Intervention type: OTHER
Intervention: No Intervention
Description: This study is the development of algorithms/models to predict eGFR values and/or classes for patients at certain time point based on entries in claims database (demographic characteristics, clinical diagnoses, procedures and drug treatments) for a general population and a variety of use-cases (AF, CAD, T2DM patients sub-populations).
Study: NCT02329522

Intervention type: DEVICE
Intervention: Ultrasonic Cardiac Output Monitor
Description: An Ultrasonic Cardiac Output Monitor (USCOM; USCOM Pty Ltd, NSW, Australia) is a non-invasive Doppler ultrasonography. It is capable of measuring haemodynamic parameters non-invasively and appears to be simple and rapid to use, portable, relatively inexpensive and has less potential complications compared with the standard technique, pulmonary artery thermodilution (PATD).~USCOM scans will be performed on patients to measure direct and derived haemodynamic variables, which will be performed in the supine position wherever possible. A transducer will be placed on the chest in either the suprasternal position to measure trans-aortic blood flow, or the left parasternal position to measure transpulmonary blood flow.
Study: NCT02256371

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relaxation group
Description: 1 relaxation session per week during 8 weeks
Study: NCT02329522

Intervention type: DEVICE
Intervention: Ultrasonic Cardiac Output Monitor
Description: An Ultrasonic Cardiac Output Monitor (USCOM; USCOM Pty Ltd, NSW, Australia) is a non-invasive Doppler ultrasonography. It is capable of measuring haemodynamic parameters non-invasively and appears to be simple and rapid to use, portable, relatively inexpensive and has less potential complications compared with the standard technique, pulmonary artery thermodilution (PATD).~USCOM scans will be performed on patients to measure direct and derived haemodynamic variables, which will be performed in the supine position wherever possible. A transducer will be placed on the chest in either the suprasternal position to measure trans-aortic blood flow, or the left parasternal position to measure transpulmonary blood flow.

Intervention type: DEVICE
Intervention: Ultrasonic Cardiac Output Monitor
Description: An Ultrasonic Cardiac Output Monitor (USCOM; USCOM Pty Ltd, NSW, Australia) is a non-invasive Doppler ultrasonography. It is capable of measuring haemodynamic parameters non-invasively and appears to be simple and rapid to use, portable, relatively inexpensive and has less potential complications compared with the standard technique, pulmonary artery thermodilution (PATD).~USCOM scans will be performed on patients to measure direct and derived haemodynamic variables, which will be performed in the supine position wherever possible. A transducer will be placed on the chest in either the suprasternal position to measure trans-aortic blood flow, or the left parasternal position to measure transpulmonary blood flow.
Study: NCT03558139

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Administered intravenously
Study: NCT05712109

Intervention type: OTHER
Intervention: Follow-up after Anterior cruciate ligament reconstruction
Description: The patients were referred to the sport medicine department for the post ACL-R follow-up including isokinetic knee muscle strength evaluations at 4 months and 8.months after the surgery
Study: NCT03463187

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SHR-1314
Description: Administered subcutaneously

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SHR-1314
Description: Administered subcutaneously
Study: NCT03558139

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Administered intravenously
Study: NCT03463187

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SHR-1314
Description: Administered subcutaneously

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SHR-1314
Description: Administered subcutaneously

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SHR-1314
Description: Administered subcutaneously

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SHR-1314
Description: Administered subcutaneously
Study: NCT05240092

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Haptonomy
Description: Haptonomy, as a field dealing with emotional contact through touch, describe the relationship between parents and the unborn baby.